Tag: Cemiplimab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cemiplimab

Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous ...

Added to Collection on: 2022-09-13 07:55:05

Tags for this article:

Lung cancer
Cemiplimab
Sanofi
Regeneron Pharmaceuticals
Squamous cell carcinoma
CSCC
Neoplasms
Health
Clinical medicine
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Fianlimab (LAG-3 Inhibitor) Combined with Libtayo® (cemiplimab ... - PipelineReview.com

Added to Collection on: 2022-09-12 07:10:23

Tags for this article:

Medicine
Clinical medicine
Medical specialties
Immune system
Cancer treatments
PD-1 and PD-L1 inhibitors
Antineoplastic drugs
Programmed cell death protein 1
PD-L1
Regeneron Pharmaceuticals
Cemiplimab
LAG3
REGENERON PHARMACEUTICALS , INC
United States

Click the tags to see associated articles and topics

View Article Details
Libtayo® (cemiplimab) Receives Positive CHMP Opinion Recommending Approval to Treat ...

Added to Collection on: 2022-10-14 20:57:20

Tags for this article:

Cancer
Clinical medicine
Health
RTT
Lung cancer
Sanofi
Infectious causes of cancer
Oncology
Regeneron Pharmaceuticals
Aflibercept
Cemiplimab
Non-small-cell lung carcinoma
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Regeneron to Showcase Progress from Innovative Oncology - GlobeNewswire

Added to Collection on: 2023-10-15 22:11:08

Tags for this article:

Cancer immunotherapy
Breakthrough therapy
Lung cancer
Cemiplimab
Sanofi
Checkpoint inhibitor
Regeneron Pharmaceuticals
Non-small-cell lung cancer
Squamous-cell carcinoma
Ovarian cancer
PD-1 and PD-L1 inhibitors
Libtayo
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Libtayo® (cemiplimab) Neoadjuvant Treatment Demonstrates - GlobeNewswire

Added to Collection on: 2023-10-21 18:51:50

Tags for this article:

Breakthrough therapy
Cemiplimab
Sanofi
Lung cancer
Regeneron Pharmaceuticals
Squamous-cell carcinoma
Radiation therapy
Clinical endpoint
PD-1 and PD-L1 inhibitors
Adenocarcinoma of the lung
Regeneron Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals ... - PipelineReview.com

Added to Collection on: 2024-01-09 15:15:16

Tags for this article:

Lung cancer
Immune system
Cemiplimab
Sanofi
Regeneron Pharmaceuticals
Cancer immunotherapy
Infectious causes of cancer
ROS1
Non-small-cell lung cancer
Squamous-cell carcinoma
Programmed cell death protein 1
Small-cell carcinoma
Regeneron Pharmaceuticals Inc.
Medison Pharma

Click the tags to see associated articles and topics

View Article Details
eFFECTOR shelves tomivosertib in NSCLC following Phase II failure - Clinical Trials Arena

Added to Collection on: 2024-04-04 22:16:45

Tags for this article:

Orphan drugs
Antineoplastic drugs
Lung cancer
Cancer immunotherapy
Pembrolizumab
Non-small-cell lung cancer
Cemiplimab

Click the tags to see associated articles and topics

View Article Details
Real-World Treatment Patterns and Outcomes of Cemiplimab in Patients w | CMAR

Added to Collection on: 2024-07-18 10:14:26

Tags for this article:

Antineoplastic drugs
Orphan drugs
Cemiplimab
Pembrolizumab
Gefitinib
Electrocorticography
Cohort study
Atezolizumab
Nivolumab
Skin cancer
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Perioperative PD-1 Inhibition Expands Treatment Opportunities for Select Patients With CSCC

Added to Collection on: 2024-07-23 20:07:13

Tags for this article:

Cemiplimab
Sanofi
Skin cancer
Immunotherapy
Cutaneous leishmaniasis
Cancer treatment
PD-1 and PD-L1 inhibitors
Cutaneous squamous-cell carcinoma

Click the tags to see associated articles and topics

View Article Details
THIO Shows Lower Toxicity Than Standard Treatments in NSCLC Study

Added to Collection on: 2024-07-25 15:07:17

Tags for this article:

Cancer immunotherapy
Thioethers
Checkpoint inhibitor
Immune system
Cemiplimab
MAIA Biotechnology
TME
Lung cancer

Click the tags to see associated articles and topics

View Article Details